
Drépanocytose : Kéni Piperol met les voiles pour la cause
Drépanocytose : ma rencontre avec Kéni Piperol à la Route du Rhum, son projet Drépavoile et les avancées de la recherche clinique. Où en est-on ?
Artificial Intelligence (AI) is here, and it’s shaking things up—even in our ultra-regulated world.


Artificial Intelligence (AI) is here, and it’s shaking things up—even in our ultra-regulated world. Whether you’re in a small CRO, a biotech SME, or part of an operational team (CRA, Clinical Site Coordinator, Contract Specialist), AI is an incredible opportunity to gain both time and consistency.
But let’s be honest: between GDPR, ICH E6(R3), and the upcoming European AI Act, it’s easy to feel lost. Where’s the line? At what point does AI become a major risk for patient safety and trial integrity?
We’ve broken down the pitfalls—from Copilot’s security challenges to the strict classification of your protocols. This guide is your practical compass to move forward with confidence.
We’ll explore together:
AI is not here to replace you—it’s here to take the weight off repetitive tasks that drain your time. Here’s where it can save you hours:
| Role | What AI Does Best (and Fast!) |
|---|---|
| CRA | Draft monitoring reports with perfect structure; Create tailored visit checklists; Help classify deviations according to ICH. |
| Clinical Site Coordinators (CSC) | Write clear procedures for eCRF entry; Prepare training guides for sites; Help respond to data management queries. |
| Contract Specialists | Adapt site CTA templates to local laws (insurance, data); Compare contract versions to spot risky changes. |
| Quality | Write well-structured deviations; Summarize and update SOPs; Build a strong CAPA plan. |
| Clinical Research Trainers | Design modular, engaging training plans; Quickly generate quizzes and knowledge checks; Turn complex regulatory updates (AI Act, ICH) into simple learning materials. |
When working with AI, the first step is drawing a clear red line.
Avoid it! Tools like ChatGPT, Claude, or Gemini are great for cooking recipes or planning holidays—but never for clinical documents.
The risk is too high: your data may be used for model retraining, threatening confidentiality and your company’s Intellectual Property (IP). Use them for personal learning only, nothing else.
Copilot is great because your data usually stays within Microsoft’s secure environment (not exposed to the public). But here’s the catch:
Copilot sees everything YOU can see. If you have access to a sensitive file, so does AI.
The danger? Poorly managed permissions! If an old contract or protocol is dumped in a folder open to all, Copilot will find it if someone asks.
On-premise setups (on your own servers) give maximum security—no data leaves your infrastructure. Perfect for control, but often too costly for small organizations.
Caution is essential. Risks around IP or personal data don’t disappear after validation.
| Level | Data Types (Examples) | What to Do |
|---|---|---|
| ❌ CRITICAL | Patient identifiers (bank details); Protocols with confidential elements (not public); Site contracts and agreements (drafted/finalized); Strategic IP (molecule, raw data). | Absolutely forbidden to use with AI. Too sensitive. |
| ⚠️ HIGH | Pseudonymized/validated monitoring reports; Critical anonymized study docs (not protocol/contract); Highly confidential internal procedures. | Limited use, always followed by systematic, traceable human validation. |
| ✅ STANDARD | Public references (ICH-GCP guidelines, regulations); Generic training checklists. | Allowed for productivity support, but always with human review. |
AI doesn’t work miracles—it’s only as good as your prompt. In clinical research, regulatory rigor is non-negotiable.
Feed AI validated document samples so it mimics the strict structure of clinical docs.
Example:
« Here are 3 examples of validated monitoring reports. Follow their exact format. Now generate a similar report for the monitoring visit on [DATE] at site [PSEUDONYMIZED]. »
Ask AI to explain its reasoning before giving the answer. Proof of logic is essential.
Example:
« Act as a senior CRA. Analyze this deviation step by step: 1) Assess impact on participant safety. 2) Assess impact on data integrity. 3) Give the final ICH-GCP classification. Justify your choice using the previous steps. »
AI struggles with complex tables, corporate logos, and Word templates. Practical tip: use AI for content (text), then finalize formatting manually. Safer and saves re-reading time.
The European AI Act is coming, and it forces us to ask: Is AI making the decision for me?
If AI makes a decision that—if wrong—could impact patient safety or trial validity, it’s high-risk. Avoid these:
| Potential High-Risk Use | Why It’s a Major Risk in Clinical Research |
|---|---|
| Clinical decision-making (dose/treatment). | An algorithm adjusting patient dosage. Immediate safety risk. |
| Automatic correction of primary data. | Tool changes data without human validation. Data integrity compromised. |
| Automatic detection of unreported SAEs. | AI decides it’s not an SAE. If wrong, you breach critical reporting obligations. |
Key takeaway: If AI replaces your decision on patient safety or primary data validity, it’s high-risk. If it simply helps you write or analyze information, it’s acceptable.
AI is powerful, but absolute rigor must remain human.
Don’t create a one-size-fits-all “AI SOP.” Each role has different risks. Procedures must reflect that.
| Role | Example of Role-Specific Rule |
|---|---|
| CRA | Ban AI use for summarizing monitoring notes before human validation, to guarantee safety data completeness. |
| Contract Specialists | Require legal department validation of all AI-generated or modified clauses—regardless of perceived risk. |
| Quality | CAPA analysis must record whether AI was used, to prevent cognitive bias in root cause analysis. |
Anticipate the AI Act: Implement a quality management system for AI.
Mandatory documentation: Draft AI-use procedures, training logs, and your AI-specific risk analysis.
AI gives us the chance to refocus on what truly matters: expertise, clinical judgment, and human relationships.
To make AI your strongest ally, you must master it with absolute rigor.
AI does not replace human expertise—it amplifies it. So, are you ready to take this next step safely?
Discover our article on « Clinical research 2.0« , english version available.
This article is intended to provide general and educational information about the potential use of artificial intelligence (AI) in clinical research.
It does not constitute regulatory guidance or operational directives.
AI is presented here as a support tool to simplify certain administrative or organizational tasks, and should in no way replace the vigilance, expertise, or regulatory responsibilities of clinical research professionals (CRAs, Study Coordinators, Investigators, Sponsors, etc.).
Each organization remains responsible for ensuring regulatory compliance (ICH-GCP, EMA, FDA, GDPR, HIPAA…) before integrating any technology into its processes.